Strep Throat Treatment Market Size, Share, and Trends 2024 to 2033

Strep Throat Treatment Market Size and Companies

The global strep throat treatment market size was USD 2.10 billion in 2023, calculated at USD 2.19 billion in 2024 and is expected to reach around USD 3.24 billion by 2033, growing at a CAGR of 4.42% from 2024 to 2033. The strep throat treatment market is driven by the rising incidence of bacterial infections.

Key Takeaways

• The North America strep throat treatment market size accounted for USD 820 million in 2023 and is expected to attain around USD 1,280 million by 2033, poised to grow at a CAGR of 4.55% between 2024 and 2033.
• North America dominated the market with the largest revenue share of 39% in 2023.
• Asia-Pacific is the fastest-growing market during the forecast period.
• By disease type, the acute strep throat segment dominated the market in 2023.
• By disease type, the tonsillitis segment shows a significant growth during the forecast period.
• By treatment type, the antibiotics segment dominated the strep throat treatment market in 2023.
• By diagnosis, the antibody test segment dominated the strep throat treatment market in 2023.
• By diagnosis, the throat culture segment is expected to show a notable growth in the strep throat treatment market during the forecast period.
• By route of administration, the oral segment has contributed more than 44% of revenue share in 2023.
• By route of administration, the injectable segment shows a notable growth in the strep throat treatment market during the forecast period.
• By end-use, the hospitals segment dominated the strep throat treatment market in 2023.
• By distribution channel, the hospital pharmacy segment dominated the strep throat treatment market in 2023.
• By distribution channel, the online pharmacy segment shows a notable growth in the strep throat treatment market during the forecast period.

U.S. Strep Throat Treatment Market Size and Growth 2024 to 2033

The U.S. strep throat treatment market size was calculated at USD 570 million in 2023 and is projected to attain around USD 900 million by 2033, poised to grow at a CAGR of 4.67% from 2024 to 2033.

North America had the largest market share in 2023 in the strep throat treatment market. Strep throat is a prevalent bacterial infection particularly common in children and adolescents. North America experiences a high number of strep throat cases every year due to its enormous population and heavily populated urban regions. There is a strong need for strep throat treatment alternatives due to the high frequency of the condition. Most people can obtain health insurance, which frequently covers prescription drugs, diagnostic testing, and physician consultations. Reimbursement regulations also guarantee that patients can afford the expense of treating strep throat, which increases demand for such treatments in the area.

Asia-Pacific is the fastest-growing strep throat treatment market during the forecast period. In several of the region's nations, healthcare accessibility and awareness have significantly increased. Governments and healthcare groups have aggressively promoted the symptoms of strep throat, the significance of prompt treatment, and awareness campaigns. The need for strep throat therapy has increased due to improved access to medical care made possible by hospitals, clinics, and diagnostic centers. In numerous Asia-Pacific nations, economic expansion has led to an increase in middle-class disposable income levels.

When people have more disposable cash, they are more likely to pay for healthcare services, including the treatment of common illnesses like strep throat. This greater affordability drives the need for strep throat remedies and drugs.

Market Overview

The pharmaceutical industry's section is dedicated to managing and curing streptococcal infections that cause throat inflammation (commonly known as strep throat) and is known as the "strep throat treatment market." Team A Highly contagious streptococcus bacteria are the leading cause of strep throat. The symptoms include fever, sore throat, dysphagia, and enlarged lymph nodes. Serious side effects such as kidney inflammation, rheumatic fever, or scarlet fever might result from untreated strep throat.

The market for strep throat remedies is significant because of what it does for public health. Reducing the strain on healthcare systems, effective treatment choices lessen the suffering brought on by strep throat and stop the virus from spreading to others. Furthermore, timely and adequate care can help prevent possible problems, enhancing patients' prognosis and quality of life.

Growth Factors

• Increasing numbers of cases of viral and bacterial diseases like influenza.
• In underdeveloped nations, unsanitary conditions contribute to the spread of infectious diseases.
• Creation of novel antibiotics to fight bacteria that are resistant to them.
• Growing interest in strep throat remedies that are both long-lasting and fast-acting.
• Enhanced awareness of the signs and consequences of strep throat in the public health domain.
• Quick strep test usage has increased to expedite diagnosis and treatment commencement.
• Putting more emphasis on tailored medication to treat strep throat.
• Increasing use of over the counter (OTC) treatments for strep throat.

Strep Throat Treatment Market Scope

Market Dynamics

Drivers

Frequency of strep throat infections

Penicillin and amoxicillin are the usual therapies for strep throat. The pharmaceutical industry is supported by the high prescription rates for these antibiotics resulting from the high incidence of illnesses. Alternative antibiotics, such as cephalosporins or macrolides, are administered to people allergic to penicillin. The range of treatments available broadens the market. Antibiotic-resistant strains of S. pyogenes are uncommon, but when they do arise, they require combination or broader-spectrum antibiotics, which changes the market dynamics by driving up demand for sophisticated treatments.

Improved diagnostic methods

With reliable diagnostics, healthcare professionals can prescribe more focused therapies and improve patient happiness and outcomes. Prompt and accurate diagnosis results in higher compliance rates, which gives patients more confidence in their diagnosis and recommended course of action.

Restraint

Limited number of effective treatment options for strep throat

Antibiotics, usually penicillin and amoxicillin, are the mainstay of treatment for strep throat. Antibiotic resistance has, however, increased due to antibiotic overuse and misuse. Due to this resistance, traditional therapies are less effective, which increases the likelihood of treatment failures and recurring infections. The effectiveness of present antibiotics decreases with increased resistance, requiring the restricted development of new medications or alternate treatments.

Opportunities

Rise of telemedicine

Patients can arrange appointments without having to wait through long waits that are frequently associated with in-person visits. This is especially helpful for urgent medical issues that need to be treated right away, like strep throat. Telemedicine makes it possible to schedule consultations outside of usual business hours, which benefits patients' schedules and raises the possibility of an early diagnosis and course of treatment.

Innovation in terms of alternative therapies

Probiotics can improve the immune system's reaction to illnesses. One interesting approach could be to create probiotic supplements or functional meals to cure or prevent strep throat. Conducting thorough clinical trials can facilitate obtaining regulatory approval and consumer trust in probiotics as a treatment for strep throat.

The creation of fast and accurate over-the-counter testing kits for strep throat can enable patients to select appropriate treatments, including non-antibiotic ones, without taking antibiotics immediately. Cutting-edge wearables that track the condition of the throat and identify early indications of infection can be linked with smartphone applications that offer recommendations for different forms of treatment.

Disease Type Insights

The acute strep throat segment dominated the strep throat treatment market in 2023. The group A Streptococcus bacterium, which causes acute strep throat, is a frequent infection, particularly in children and teenagers. There is a substantial need for medical consultations and treatments due to the high incidence rate. According to statistics from healthcare organizations, millions of instances are recorded globally each year, with a noteworthy concentration in younger groups and during specific seasons (fall and winter).

The timely diagnosis and treatment of acute strep throat is facilitated by the accessibility of healthcare facilities and the availability of diagnostic techniques such as throat cultures and rapid antigen detection tests (RADTs). This market segment's supremacy is bolstered by industrialized countries' well-established infrastructure and developing countries' expanding access to healthcare.

The tonsillitis segment shows a significant growth in the strep throat treatment market during the forecast period. Raising knowledge of the signs and consequences of tonsillitis and strep throat has been facilitated by public health initiatives and better healthcare facilities. Improved diagnostic tools, such as throat cultures and rapid antigen detection tests (RADTs), provide more precise and timely diagnoses, which enable prompt treatment approaches. The prevalence of respiratory and throat infections has increased due to lifestyle variables such as increased pollution and environmental changes. There is a growing demand for efficient treatment alternatives for tonsillitis due to factors such as urbanization and changes in living situations that may increase the disease's incidence.

Treatment Type Insights

The antibiotics segment dominated the strep throat treatment market in 2023. Due to their tremendous efficacy, primarily penicillin and amoxicillin, antibiotics have been the mainstay of care for strep throat. The bacterium that causes strep throat, Streptococcus pyogenes, is susceptible to these medications. Antibiotics are the recommended course of treatment because they can quickly relieve symptoms, shorten the length of the disease, and avoid complications, including post-streptococcal glomerulonephritis and rheumatic fever. Health organizations' public awareness campaigns and educational initiatives stress the significance of using antibiotics to treat bacterial diseases like strep throat. This awareness among patients and caregivers fuels the demand for prescription antibiotics when strep throat is identified.

Diagnosis Insights

The antibody test segment dominated the strep throat treatment market in 2023. Antibody tests are very reliable and accurate in diagnosing strep throat. They identify antibodies directed against the strep throat-causing Streptococcus pyogenes bacteria. The high specificity and sensitivity of these tests decrease the likelihood of false positives and negatives. Due to their dependability, patients are guaranteed accurate diagnoses, which facilitates prompt and effective treatment. The performance of antibody testing has increased dramatically due to advancements in diagnostic technologies. Due to improved test kits with improved detection capabilities and user-friendly designs, more healthcare providers, including pediatricians, pharmacists, and primary care physicians in some areas, can now obtain these tests.

The throat culture segment shows a notable growth in the strep throat treatment market during the forecast period. When compared to other diagnostic techniques like rapid antigen detection tests (RADTs), throat cultures are thought to be the gold standard for strep throat diagnosis since they yield incredibly accurate and dependable results. This precision is essential for ensuring that the right antibiotics are used, lowering the possibility of problems and the prevalence of antibiotic resistance. Technological advancements in microbiology and diagnostics have enhanced the effectiveness and velocity of throat cultures. Healthcare professionals find throat cultures more appealing because of automated systems and improved culture mediums that improve the detection of Group A Streptococcus.

Route of Administration Insights

The oral segment dominated and expected to sustain the strep throat treatment market in 2023. Penicillin and amoxicillin are two oral antibiotics that work wonders for strep throat. They function by preventing the growth of pathogenic germs, offering dependable and prompt symptom alleviation. IV therapies are more difficult to give than oral drugs. Patients can easily take liquids or pills at home, negating the need for professional monitoring or hospital visits.

The use of telemedicine, in which doctors may diagnose strep throat and remotely dispense oral antibiotics, has increased because of the COVID-19 epidemic. This convenience has strengthened the desire for oral medicines. The demand for oral antibiotics was further stimulated by the increased preference for at-home treatments during the epidemic.

The injectable segment shows a notable growth in the strep throat treatment market during the forecast period. Increasing concerns over antibiotic resistance have fueled the desire for more efficient treatment modalities. Considering their greater potency and capacity to enter the bloodstream directly, injectable antibiotics are vital against Streptococcus pyogenes strains that have developed resistance. In some cases, this tendency supports injectables as a first-line treatment, driving up the market for these products.

End-use Insights

The hospitals segment dominated the strep throat treatment market in 2023. Hospitals can diagnose strep throat accurately and quickly because of their state-of-the-art laboratory facilities and diagnostic instruments. This capacity, which is frequently less easily accessible in smaller clinics or at home, is essential for initiating treatment in a timely and suitable manner. Hospitals are the principal facilities capable of providing appropriate inpatient care and surgical interventions for severe instances of strep throat that may require hospitalization, such as those leading to complications such as peritonsillar abscess.

Distribution Channel Insights

The hospital pharmacy segment dominated the strep throat treatment market in 2023. Hospital facilities are usually the preferred location for managing severe instances of strep throat, as they may involve complications or necessitate hospitalization. A more comprehensive therapeutic strategy, including intravenous antibiotics, which hospital pharmacies provide, is frequently required for these instances. The hospital pharmacy segment's supremacy is further reinforced by its ability to treat complex and severe cases. Because of their ties with more extensive healthcare networks and their bulk purchasing agreements, hospital pharmacies occasionally provide competitive pharmaceutical pricing. As a result, patients may find it easier to pay for their care, which may motivate them to use the hospital's pharmacy services.

The online pharmacy segment shows a notable growth in the strep throat treatment market during the forecast period. Online pharmacies provide unmatched accessibility and convenience. It is quite helpful for people with strep throat to be able to get drugs online and have them delivered right to their homes. Strep throat frequently causes extreme fever and throat pain. This is particularly important for isolated or rural communities without access to traditional pharmacies. Many customers use online pharmacies due to increased knowledge and instruction on their availability and advantages. Online pharmacy services are becoming increasingly popular due to campaigns run by online pharmacies and healthcare providers that emphasize the services' affordability, security, and ease of use.

Strep Throat Treatment Market Companies

• Pfizer Inc.
• AstraZeneca
• Novartis AG
• Bayer AG
• GSK Plc.
• Amgen Inc.
• Merck & Co, Inc.
• Sanofi
• Mitsubishi Chemical Group Corp.
• Teva Pharmaceutical Industries Ltd.
• Melinta Therapeutics

Recent Developments

• In October 2023, Northern Ireland declared pharmacy sore throat and extended UTI services.
• In August 2023, Walmart launched the latest testing and treatment program, which it declared will be available at pharmacies in 12 states, including Arkansas. As per the press release, this will allow patients experiencing respiratory symptoms to get tested to regulate the cause of their symptoms and, if eligible, to be prescribed medication to assist in treating and directing those symptoms in one place on the same day, seven days a week.

Segments Covered in the Report

By Disease Type

• Acute Strep Throat
• Pharyngitis
• Tonsillitis
• Laryngitis

By Treatment Type

• Antibiotics
• Pain Relievers

By Diagnosis

• Antibody Test
• Physical Examination
• Throat Culture

By Route Of Administration

• Oral
• Topical
• Injectable

By End-use

• Hospitals
• Specialty Clinics
• Diagnostic Laboratories

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa